⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11381299 | 0.91 | HRH4 (0.32) | — | |
| SCHEMBL27468917 | 0.86 | NISCH (0.30) | — | |
| SCHEMBL27450276 | 0.84 | NISCH (0.33) | — | |
| SCHEMBL27468490 | 0.84 | NISCH (0.33) | — | |
| SCHEMBL2121563 | 0.84 | — | — | |
| SCHEMBL27449730 | 0.82 | — | — | |
| SCHEMBL1545610 | 0.75 | HRH4 (0.33) | — | |
| SCHEMBL19348445 | 0.73 | — | — | |
| SCHEMBL14823372 | 0.71 | CHRM5 (0.38) | — | |
| SCHEMBL15924379 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3548090-A1 | CONJUGATES COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST, A LINKER AND HYALURONIC ACID | Sanofi (FR) | 2019-10-09 | — | — | EP | disclosed |
| WO-2018100174-A1 | CONJUGATES COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST, A LINKER AND HYALURONIC ACID | SANOFI (FR) | 2018-06-07 | — | — | WO | disclosed |
| EP-3302567-A1 | PRODRUGS COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST LINKER HYALURONIC ACID CONJUGATE | SANOFI (FR) | 2018-04-11 | — | — | EP | disclosed |
| EP-3242689-A1 | CNP PRODRUGS | Ascendis Pharma Growth Disorders A/S (DK) | 2017-11-15 | — | — | EP | disclosed |
| WO-2016193371-A1 | PRODRUGS COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST LINKER HYALURONIC ACID CONJUGATE | SANOFI (FR) | 2016-12-08 | — | — | WO | disclosed |
| WO-2016110577-A1 | CNP PRODRUGS | ASCENDIS PHARMA A/S (DK) | 2016-07-14 | — | — | WO | disclosed |
| EP-2616102-A1 | PRODRUGS COMPRISING AN EXENDIN LINKER CONJUGATE | Sanofi-Aventis Deutschland GmbH (DE) | 2013-07-24 | — | — | EP | disclosed |
| EP-2443087-A1 | DISUBSTITUTED-AMINODIFLUOROSULFINIUM SALTS, PROCESS FOR PREPARING SAME AND METHOD OF USE AS DEOXOFLUORINATION REAGENTS | Omegachem Inc. (CA) | 2012-04-25 | — | — | EP | disclosed |
| WO-2012035139-A1 | PRODRUGS COMPRISING AN EXENDIN LINKER CONJUGATE | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2012-03-22 | — | — | WO | disclosed |
| EP-2279007-A2 | PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS | Ascendis Pharma AS (DK) | 2011-02-02 | — | — | EP | disclosed |
| WO-2010145037-A1 | DISUBSTITUTED-AMINODIFLUOROSULFINIUM SALTS, PROCESS FOR PREPARING SAME AND METHOD OF USE AS DEOXOFLUORINATION REAGENTS | OMEGACHEM INC. (CA) | 2010-12-23 | — | — | WO | disclosed |
| WO-2009133137-A2 | PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS | ASCENDIS PHARMA AS (DK) | 2009-11-05 | — | — | WO | disclosed |
| EP-1909845-A2 | N,N-BIS-(2-HYDROXYETHYL) GLYCINE AMIDE AS LINKER IN POLYMER CONJUGATED PRODRUGS | Complex Biosystems GmbH (DE) | 2008-04-16 | — | — | EP | disclosed |
| EP-1781335-A2 | HYDROGEL POLYMERIC CONJUGATES OF A PRODRUG | Complex Biosystems GmbH (DE) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006136586-A2 | N, N-BIS- (2-HYDROXYETHYL) GLYCINE AMIDE AS LINKER IN POLYMER CONJUGATED PRODRUGS | COMPLEX BIOSYSTEMS GMBH (DE) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006003014-A2 | HYDROGEL POLYMERIC CONJUGATES OF A PRODRUG | COMPLEX BIOSYSTEMS GMBH (DE) | 2006-01-12 | — | — | WO | disclosed |
| EP-0735992-A1 | METHOD OF CONVERTING HYDROXYL GROUPS INTO CORRESPONDING FLUORO COMPOUNDS | BAYER AG (DE) | 1996-10-09 | — | — | EP | disclosed |
| WO-1996013474-A1 | METHOD OF CONVERTING HYDROXYL GROUPS INTO CORRESPONDING FLUORO COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-05-09 | — | — | WO | disclosed |